Sorbonne University, GRC 29, DMU DREAM.
Department of Anesthesiology and Intensive Care, Hôpital Saint-Antoine.
Int J Surg. 2023 Nov 1;109(11):3555-3565. doi: 10.1097/JS9.0000000000000619.
Surgery induces high rates of cognitive disorders, persisting for up to 12 months in elderly adults. This review aimed to assess the currently debated preventive effect of perioperative ketamine on postoperative delirium and postoperative neurocognitive disorders (POND).
Systematic review and meta-analysis including all randomized controlled trials investigating the effects of perioperative ketamine administration in adult patients compared to placebo or no intervention on postoperative delirium and/or POND between January 2007 and April 2022. Database searches were conducted in PubMed, Medline, Embase, Scopus, and Central. Random effects models were used to pool overall estimates. The GRADE approach was used to assess the quality of the evidence.
From 1379 records screened, 14 randomized controlled trials with 1618 patients randomized met our inclusion criteria with a high level of consensus among reviewers, amongst whom 50% were at low-moderate risk of bias. There was no between-group difference in postoperative delirium [8 trials, 1265 patients, odds ratio (OR) 0.93, 95% CI (0.51-1.70), I2 =28%] and POND [5 trials, 494 patients, OR 0.52, 95% CI (0.15-1.80); I2 =78%]. There was no significant between-group difference in postoperative psychological adverse effects, level of pain, hospital length of stay, or mortality. Between-group subgroup analyses showed no difference in delirium or POND incidence according to surgical setting, ketamine dose, mode of administration, combination or not with other drug(s), and assessment timing or definition of cognitive disorders.
Perioperative ketamine does not prevent postoperative delirium or POND. Significant study heterogeneity suggests that standardized measures for POND assessment and a specific focus on patients at high risk for POND should be used to improve the comparability of future studies.
手术会导致认知障碍发生率升高,老年人术后认知障碍可持续长达 12 个月。本综述旨在评估围手术期氯胺酮预防术后谵妄和术后神经认知障碍(POND)的目前存在争议的效果。
系统评价和荟萃分析,纳入 2007 年 1 月至 2022 年 4 月期间所有比较成人患者围手术期使用氯胺酮与安慰剂或无干预对术后谵妄和/或 POND 影响的随机对照试验。在 PubMed、Medline、Embase、Scopus 和 Central 数据库中进行检索。使用随机效应模型汇总总体估计值。使用 GRADE 方法评估证据质量。
从筛选出的 1379 条记录中,有 14 项随机对照试验(共 1618 名患者)符合纳入标准,且综述作者之间存在高度共识,其中 50%的作者存在低-中度偏倚风险。术后谵妄[8 项试验,1265 名患者,比值比(OR)0.93,95%置信区间(CI)(0.51-1.70),I2 =28%]和 POND[5 项试验,494 名患者,OR 0.52,95% CI(0.15-1.80);I2 =78%]两组间无差异。两组间术后心理不良事件、疼痛程度、住院时间或死亡率无显著差异。组间亚组分析显示,手术类型、氯胺酮剂量、给药方式、与其他药物(或不与其他药物)联合使用、认知障碍评估时间或定义不同,谵妄或 POND 发生率无差异。
围手术期氯胺酮不能预防术后谵妄或 POND。显著的研究异质性表明,应该使用标准化的 POND 评估措施和特别关注 POND 高危患者,以提高未来研究的可比性。